Hôpital Universitaire Necker Enfants Malades — Paris

Public research footprint of Hôpital Universitaire Necker Enfants Malades, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Diabetes Mellitus, Type 1 · Neonatal Diabetes Secondary to Mutation in the Potassium Channel · Systemic Juvenile Idiopathic Arthritis · Hypochondroplasia

Recently updated registry entries

NCT06152575 — MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People… (Recruiting)
NCT07222332 — A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults… (Recruiting)
NCT07222137 — A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Hôpital Universitaire Necker Enfants Malades?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.